Information on total number of voting rights and shares composing the share capital as at November 30, 2023 Download PDF Antoine Balavoine2023-12-07T17:47:36+01:00December 7th, 2023|Other Regulated Information|
Commercial Court hearing to examine the takeover offer scheduled for December 18, 2023 Download PDF Antoine Balavoine2023-12-05T11:13:18+01:00December 4th, 2023|Press Releases|
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators Download PDF Antoine Balavoine2023-11-20T18:57:16+01:00November 20th, 2023|Press Releases|
OCA follow-up – Situation on November 15, 2023 Download PDF Antoine Balavoine2023-11-15T09:24:08+01:00November 15th, 2023|Other Regulated Information|
OCA follow-up – Situation on November 14, 2023 Download PDF Antoine Balavoine2023-11-14T14:04:08+01:00November 14th, 2023|Other Regulated Information|
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Download PDF Antoine Balavoine2023-11-14T08:33:30+01:00November 14th, 2023|Press Releases|
Pixium Vision announces the conversion of the safeguard proceedings into receivership Download PDF Antoine Balavoine2023-11-13T19:49:40+01:00November 13th, 2023|Press Releases|
OCA follow-up – Situation on November 10, 2023 Download PDF Antoine Balavoine2023-11-10T12:22:01+01:00November 10th, 2023|Other Regulated Information|
OCA follow-up – Situation on November 7, 2023 Download PDF Antoine Balavoine2023-11-07T22:05:21+01:00November 7th, 2023|Other Regulated Information|
OCA follow-up – Situation on November 6, 2023 Download the PDF Antoine Balavoine2023-11-06T09:19:31+01:00November 6th, 2023|Other Regulated Information|